Cargando…

Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients

BACKGROUND: Acute Hepatic Porphyrias (AHPs) are characterized by an acute neuroabdominal syndrome including both neuropsychiatric symptoms and neurodegenerative changes. Two main hypotheses explain the pathogenesis of nervous system dysfunction: (a) the ROS generation by autooxidation of 5‐aminolevu...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, María del Carmen, Cerbino, Gabriela Nora, Granata, Bárbara Xoana, Batlle, Alcira, Parera, Victoria Estela, Rossetti, María Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172188/
https://www.ncbi.nlm.nih.gov/pubmed/33764674
http://dx.doi.org/10.1002/mgg3.1059
_version_ 1783702491013054464
author Martinez, María del Carmen
Cerbino, Gabriela Nora
Granata, Bárbara Xoana
Batlle, Alcira
Parera, Victoria Estela
Rossetti, María Victoria
author_facet Martinez, María del Carmen
Cerbino, Gabriela Nora
Granata, Bárbara Xoana
Batlle, Alcira
Parera, Victoria Estela
Rossetti, María Victoria
author_sort Martinez, María del Carmen
collection PubMed
description BACKGROUND: Acute Hepatic Porphyrias (AHPs) are characterized by an acute neuroabdominal syndrome including both neuropsychiatric symptoms and neurodegenerative changes. Two main hypotheses explain the pathogenesis of nervous system dysfunction: (a) the ROS generation by autooxidation of 5‐aminolevulinic acid accumulated in liver and brain; (b) liver heme deficiency and in neural tissues that generate an oxidative status, a component of the neurodegenerative process. METHODS: We review results obtained from Acute Intermittent Porphyria (AIP) and Variegate Porphyria (VP) families studied at clinical, biochemical, and molecular level at the CIPYP in Argentina. The relationship between the porphyric attack and oxidative stress was also evaluated in AHP patients and controls, to identify a marker of neurological dysfunction. RESULTS: We studied 116 AIP families and 30 VP families, 609 and 132 individuals, respectively. Genotype/phenotype relation was studied. Oxidative stress parameters and plasma homocysteine levels were measured in 20 healthy volunteers, 22 AIP and 12 VP individuals. CONCLUSION: No significant difference in oxidative stress parameters and homocysteine levels between the analyzed groups were found.
format Online
Article
Text
id pubmed-8172188
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81721882021-06-11 Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients Martinez, María del Carmen Cerbino, Gabriela Nora Granata, Bárbara Xoana Batlle, Alcira Parera, Victoria Estela Rossetti, María Victoria Mol Genet Genomic Med Original Articles BACKGROUND: Acute Hepatic Porphyrias (AHPs) are characterized by an acute neuroabdominal syndrome including both neuropsychiatric symptoms and neurodegenerative changes. Two main hypotheses explain the pathogenesis of nervous system dysfunction: (a) the ROS generation by autooxidation of 5‐aminolevulinic acid accumulated in liver and brain; (b) liver heme deficiency and in neural tissues that generate an oxidative status, a component of the neurodegenerative process. METHODS: We review results obtained from Acute Intermittent Porphyria (AIP) and Variegate Porphyria (VP) families studied at clinical, biochemical, and molecular level at the CIPYP in Argentina. The relationship between the porphyric attack and oxidative stress was also evaluated in AHP patients and controls, to identify a marker of neurological dysfunction. RESULTS: We studied 116 AIP families and 30 VP families, 609 and 132 individuals, respectively. Genotype/phenotype relation was studied. Oxidative stress parameters and plasma homocysteine levels were measured in 20 healthy volunteers, 22 AIP and 12 VP individuals. CONCLUSION: No significant difference in oxidative stress parameters and homocysteine levels between the analyzed groups were found. John Wiley and Sons Inc. 2021-03-25 /pmc/articles/PMC8172188/ /pubmed/33764674 http://dx.doi.org/10.1002/mgg3.1059 Text en © 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Martinez, María del Carmen
Cerbino, Gabriela Nora
Granata, Bárbara Xoana
Batlle, Alcira
Parera, Victoria Estela
Rossetti, María Victoria
Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients
title Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients
title_full Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients
title_fullStr Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients
title_full_unstemmed Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients
title_short Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients
title_sort clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of argentine patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172188/
https://www.ncbi.nlm.nih.gov/pubmed/33764674
http://dx.doi.org/10.1002/mgg3.1059
work_keys_str_mv AT martinezmariadelcarmen clinicalbiochemicalandgeneticcharacterizationofacutehepaticporphyriasinacohortofargentinepatients
AT cerbinogabrielanora clinicalbiochemicalandgeneticcharacterizationofacutehepaticporphyriasinacohortofargentinepatients
AT granatabarbaraxoana clinicalbiochemicalandgeneticcharacterizationofacutehepaticporphyriasinacohortofargentinepatients
AT batllealcira clinicalbiochemicalandgeneticcharacterizationofacutehepaticporphyriasinacohortofargentinepatients
AT pareravictoriaestela clinicalbiochemicalandgeneticcharacterizationofacutehepaticporphyriasinacohortofargentinepatients
AT rossettimariavictoria clinicalbiochemicalandgeneticcharacterizationofacutehepaticporphyriasinacohortofargentinepatients